Primary Stroke Prevention: Medical Therapy Versus Revascularization

Area of Science:

• Cardiovascular Medicine
• Neurology
• Vascular Surgery

Background:

• Asymptomatic carotid-artery atherosclerotic vascular disease is a significant risk factor for major adverse cardiovascular events, including ischemic stroke.
• The risk associated with this condition extends beyond cerebrovascular events to include other vascular territories, such as myocardial infarction.
• While observational data highlight broad cardiovascular risks, randomized trials specifically targeting carotid stenosis have demonstrated benefits in stroke reduction for selected patients.

Purpose of the Study:

• To emphasize the comprehensive risk stratification and management strategies for patients with asymptomatic carotid artery disease.
• To highlight the necessity of a multifaceted approach to primary prevention in this patient population.

Main Methods:

• Review of observational and registry analyses concerning cardiovascular risk in patients with asymptomatic carotid atherosclerosis.
• Analysis of findings from randomized trials focused on the treatment of carotid stenosis.
• Synthesis of evidence to inform primary prevention strategies.

Main Results:

• Asymptomatic carotid atherosclerosis is linked to an increased risk of major adverse cardiovascular events, encompassing ischemic stroke and myocardial infarction.
• Randomized trials confirm that treating carotid stenosis can reduce the risk of ischemic stroke in appropriately selected individuals.
• The overall cardiovascular risk in these patients exceeds that solely attributable to carotid atherosclerosis.

Conclusions:

• Primary prevention in patients with stable carotid disease requires a comprehensive strategy.
• This strategy must address both cerebrovascular-specific risks and overall cardiovascular risk.
• Intensive medical therapies and lifestyle modifications are essential components of managing patients with asymptomatic carotid artery disease.